Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Contract Renewals

7 Feb 2006 07:00

e2v technologies PLC07 February 2006 7 February 2006 e2v secures two contract renewals worth £21m e2v technologies announces it has won two contract renewals worth a total of£21m. Both contracts are for existing OEM customers and are for products within e2v'selectronic tubes product group for use within radiotherapy cancer treatmentsystems. These products generate and deliver the exceptional levels of microwave powerrequired to drive the linear accelerator within radiotherapy systems, whichconvert the microwave power to X-rays used both in the imaging and radiationtreatment of tumours. e2v has been supporting this important application for inexcess of 30 years and works closely with OEM customers to improve theperformance and reliability of their systems. The largest of the contracts, worth £17m, and with delivery over a 3 yearperiod, is to supply Elekta, headquartered in Sweden with manufacturingfacilities in the UK and China. The second contract, worth $7m (£4m), is with TomoTherapy(R) Inc, based inWisconsin, USA. Delivery is scheduled over a 12 month period. Keith Attwood, Chief Executive of e2v said: "The renewal of these two contracts reinforces our position as a strategicsupplier into the radiotherapy equipment market and is entirely consistent withguidance given in our Interim Report and Accounts issued in December 2005." For further information: e2v technologies plc Tel: 01245 493493Keith Attwood/Mike Hannantwww.e2v.com Gavin Anderson & Company Tel: 020 7554 1400Charlotte Stone/Keith Brookbank NOTES FOR EDITORS e2v technologies plc e2v technologies delivers the radio frequency and sensing technology thatenables some of the world's most innovative medical and science, aerospace anddefence, and industrial and commercial systems. For the year ended 31 March2005, e2v achieved sales of £100.5m. It is listed on the London Stock Exchange(e2v.l). e2v is a leading developer and manufacturer of high-technology electroniccomponents and subsystems, which it supplies into three core areas: •Medical & Science : Sensor technology includes Dental X-ray, Mammography, life science applications and X-ray microscopy. Electronic Tubes are the enabling technology behind radiotherapy cancer treatments, microwave medical therapy and high-energy physics. •Aerospace & Defence : Sensor technology includes military surveillance, targeting and guidance; space-based imaging and astronomy and radar & electronic warfare. Electronic tubes provide the enabling technology behind radars, electronic countermeasures (ECM), electronic warfare and satellite communications. •Commercial & Industrial : Sensor technology includes marine radars, industrial safety sensors, automotive radars and alarms and thermal imaging cameras used by fire fighters. Electronic tubes provide enabling technology behind TV broadcast, satellite communications, marine radar and food & industrial processing. e2v has 1,300 employees worldwide with offices in UK, USA, Germany, France,Canada and a presence in China through the China Britain Business Council, aswell as a network of distributors covering other key territories. Further information on e2v technologies plc is available from its website,www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Mar 20154:45 pmRNSHoldings in Company
19th Feb 201512:56 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Feb 20154:04 pmRNSTotal Voting Rights
30th Jan 20157:00 amRNSQuater three update
22nd Jan 20152:24 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jan 20152:55 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Dec 20141:30 pmRNSTR-1: Notification of Major Interest in Shares
14th Nov 20143:27 pmRNSTR-1: Notification of Major Interest in Shares
11th Nov 20144:00 pmRNSTR-1: Notification of Major Interest in Shares
11th Nov 20143:43 pmRNSTR-1: Notification of Major Interest in Shares
11th Nov 20143:42 pmRNSTR-1: Notification of Major Interest in Shares
10th Nov 20144:07 pmRNSDirector/PDMR Shareholding - Replacement
10th Nov 20142:52 pmRNSDirector/PDMR Shareholding
10th Nov 20147:00 amRNSHalf Yearly Results
30th Oct 20148:38 amRNSTR-1: Notification of Major Interest in Shares
30th Oct 20148:35 amRNSTR-1: Notification of Major Interest in Shares
16th Oct 20147:00 amRNSPeriod End Update
22nd Sep 20143:37 pmRNSHolding(s) in Company
17th Sep 20148:39 amRNSNotice of Interim Results Announcement
15th Sep 201410:09 amRNSHolding(s) in Company
8th Sep 20142:17 pmRNSDirector/PDMR Shareholding
5th Sep 20143:34 pmRNSHolding(s) in Company
4th Sep 20142:53 pmRNSCompletion of acquisition
2nd Sep 20144:06 pmRNSTotal Voting Rights
8th Aug 201410:21 amRNSAwards under Long Term Incentive Plan
4th Aug 20142:36 pmRNSDirector/PDMR Shareholding
4th Aug 20141:45 pmRNSHolding(s) in Company
4th Aug 20147:08 amRNSAcquisition of AnaFocus
16th Jul 20149:56 amRNSResult of AGM
16th Jul 20147:00 amRNSInterim Management Statement
1st Jul 201412:18 pmRNSHolding(s) in Company
25th Jun 20143:02 pmRNSHolding(s) in Company
16th Jun 20144:20 pmRNSNotice of AGM
16th Jun 20144:15 pmRNSHolding(s) in Company
13th Jun 20141:25 pmRNSHolding(s) in Company
23rd May 20141:56 pmRNSHolding(s) in Company
19th May 20147:00 amRNSFinal Results
15th Apr 20147:00 amRNSTrading Statement
17th Mar 20144:47 pmRNSHolding(s) in Company
13th Mar 20143:08 pmRNSAwards under Share Incentive Plan
25th Feb 20147:00 amRNSChange of Director Details
21st Feb 20142:03 pmRNSHolding(s) in Company
3rd Feb 20145:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20145:00 pmRNSTotal Voting Rights
3rd Feb 20145:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20145:00 pmRNSTransaction in Own Shares
31st Jan 201412:10 pmRNSHolding(s) in Company
31st Jan 20147:00 amRNSInterim Management Statement
28th Jan 20147:00 amRNSDirector Declaration
28th Jan 20147:00 amRNSAppointment of Chief Executive - Start Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.